NDC Package 0615-8180-39 Carbidopa And Levodopa

Tablet, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0615-8180-39
Package Description:
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code:
Proprietary Name:
Carbidopa And Levodopa
Non-Proprietary Name:
Carbidopa And Levodopa
Substance Name:
Carbidopa; Levodopa
Usage Information:
Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
11-Digit NDC Billing Format:
00615818039
NDC to RxNorm Crosswalk:
  • RxCUI: 308988 - carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet
  • RxCUI: 308988 - carbidopa (as carbidopa monohydrate) 25 MG / levodopa 100 MG Extended Release Oral Tablet
  • RxCUI: 308988 - Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet
  • RxCUI: 308989 - carbidopa 50 MG / levodopa 200 MG Extended Release Oral Tablet
  • RxCUI: 308989 - carbidopa (as carbidopa monohydrate) 50 MG / levodopa 200 MG Extended Release Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ncs Healthcare Of Ky, Llc Dba Vangard Labs
    Dosage Form:
    Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA077828
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-23-2007
    End Marketing Date:
    07-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0615-8180-39?

    The NDC Packaged Code 0615-8180-39 is assigned to a package of 30 tablet, extended release in 1 blister pack of Carbidopa And Levodopa, a human prescription drug labeled by Ncs Healthcare Of Ky, Llc Dba Vangard Labs. The product's dosage form is tablet, extended release and is administered via oral form.

    Is NDC 0615-8180 included in the NDC Directory?

    Yes, Carbidopa And Levodopa with product code 0615-8180 is active and included in the NDC Directory. The product was first marketed by Ncs Healthcare Of Ky, Llc Dba Vangard Labs on August 23, 2007.

    What is the 11-digit format for NDC 0615-8180-39?

    The 11-digit format is 00615818039. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20615-8180-395-4-200615-8180-39